Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102417
Figure 1 Upregulated SNHG5 expression is associated with 5-fluorouracil resistance in colorectal cancer.
A and B: The expression levels of SNHG5 were assessed in collected samples [normal tissues = 16, colorectal cancer (CRC) tissues = 36] and The Cancer Genome Atlas database; C: The expression of SNHG5 was evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) in CRC cell lines (LOVO, HT-29, HCT-8, and SW116) compared to normal colorectal epithelial cell line; D: The expression levels of SNHG5 were examined in the 5-fluorouracil (5-Fu)-sensitive and 5-Fu-resistant CRC groups; E and F: SNHG5 expression levels in HT-29 and HT-29/5-Fu or LOVO and LOVO/5-Fu cells were assessed by qRT-PCR. bP < 0.01. 5-Fu: 5-fluorouracil; CRC: Colorectal cancer.
- Citation: Wang B, Zhou Q, Cheng CE, Gu YJ, Jiang TW, Qiu JM, Wei GN, Feng YD, Ren LH, Shi RH. Long noncoding RNA SNHG5 promotes 5-fluorouracil resistance in colorectal cancer by regulating miR-26b/p-glycoprotein axis. World J Gastrointest Oncol 2025; 17(5): 102417
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/102417.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.102417